Copyright
©The Author(s) 2004.
World J Gastroenterol. Jun 1, 2004; 10(11): 1547-1550
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1547
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1547
Characteristics | Female (n = 39) | Male (n = 260) | P |
Age (yr) | 56.4 ± 15.2 | 52.6 ± 13.2 | NS |
Underlying cirrhosis (+:-) | 36:3 | 251:9 | NS |
Viral hepatitis marker | |||
HBsAg (+:-) | 18:21 | 147:113 | NS |
Anti-HCV (+:-) | 5:34 | 23:237 | NS |
Heavy alcohol consumption (+:-) | 3:36 | 83:177 | 0.002 |
Mean AFP (IU/mL) | 48435.4 ± 105231.6 | 40221.9 ± 89147.9 | NS |
Biochemical liver function tests | |||
Total bilirubin (mg/dL) | 1.5 ± 1.2 | 3.1 ± 2.3 | 0.03 |
Alkaline phosphatase (IU/L) | 451.6 ± 277.3 | 529.3 ± 375.0 | NS |
AST (IU/L) | 128.4 ± 133.2 | 154.3 ± 135.2 | NS |
ALT (IU/L) | 62.7 ± 52.6 | 87.6 ± 97.5 | NS |
Albumin (g/dL) | 3.6 ± 0.7 | 3.4 ± 0.7 | NS |
Prothrombin time (sec) | 14.5 ± 2.8 | 15.1 ± 9.3 | NS |
Characteristics | Female (n = 39) | Male (n = 260) | P |
Mean tumor size (cm) | 8.1 ± 3.9 | 11.6 ± 4.5 | 0.02 |
Tumor size | |||
≤5 cm:> 5 cm | 9:30 | 30:230 | 0.04 |
Gross appearance of HCC | |||
Nodular:Multinodular:Massive:Diffuse | 12:10:14:3 | 30:52:115:63 | 0.01 |
Tumor cell differentiation | |||
Well:Moderately:Poorly | 3:5:4 | 11:66:32 | NS |
Okuda’ s staging (I:II:III) | 13:23:3 | 43:180:37 | 0.04 |
Portal or hepatic vein invasion (+:-) | 6:33 | 84:176 | 0.03 |
Extrahepatic metastasis (+:-) | 5:34 | 37:223 | NS |
Ruptured HCC (+:-) | 1:38 | 29:231 | NS |
Therapy for HCC (+:-) | 22:17 | 105:155 | NS |
Modality of therapy | |||
Surgical resection (+:-) | 9:30 | 27:233 | 0.02 |
Chemoembolization (+:-) | 13:26 | 43:217 | 0.01 |
Systemic chemotherapy (+:-) | 0:39 | 31:229 | 0.02 |
Variables | Regression coefficient (95% CI) | P value1 |
AFP (> 400 IU/mL) | 1.67 (1.03-2.71) | 0.037 |
Portal or hepatic vein invasion | 1.73 (1.04-2.89) | 0.035 |
Extrahepatic metastasis | 2.37 (1.30-4.37) | 0.005 |
No therapy | 2.87 (1.63-5.04) | 0.0002 |
- Citation: Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(11): 1547-1550
- URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1547.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1547